Trading portfolio This morning I bought into Clinuvel Pharmaceuticals (CUV, $9.99 up 41¢, $477m) at $10.10 on yesterday’s chart breakout. The shares actually got as high as $10.50 today before reacting back. On the fundamentals, there was nothing much to cause this strength and I am aware that the mkt cap looks high in relation … Read more
To access this post, you must purchase a membership.